157 related articles for article (PubMed ID: 32850348)
1. A Nomogram Modeling
Zhou W; Zhou Z; Wen J; Xie F; Zhu Y; Zhang Z; Xiao J; Chen Y; Li M; Guan Y; Hua T
Front Oncol; 2020; 10():1200. PubMed ID: 32850348
[No Abstract] [Full Text] [Related]
2. Development and validation of clinical-radiomics analysis for preoperative prediction of IDH mutation status and WHO grade in diffuse gliomas: a consecutive L-[methyl-11C] methionine cohort study with two PET scanners.
Zhou W; Wen J; Huang Q; Zeng Y; Zhou Z; Zhu Y; Chen L; Guan Y; Xie F; Zhuang D; Hua T
Eur J Nucl Med Mol Imaging; 2024 Apr; 51(5):1423-1435. PubMed ID: 38110710
[TBL] [Abstract][Full Text] [Related]
3. Integrated CT Radiomics Features Could Enhance the Efficacy of
Zhou W; Huang Q; Wen J; Li M; Zhu Y; Liu Y; Dai Y; Guan Y; Zhou Z; Hua T
Front Oncol; 2021; 11():772703. PubMed ID: 34869011
[TBL] [Abstract][Full Text] [Related]
4. Heterogeneous parameters based on
Hua T; Zhou W; Zhou Z; Guan Y; Li M
Quant Imaging Med Surg; 2021 Jan; 11(1):317-327. PubMed ID: 33392031
[TBL] [Abstract][Full Text] [Related]
5. Non-invasive prediction of IDH-wildtype genotype in gliomas using dynamic
Vettermann F; Suchorska B; Unterrainer M; Nelwan D; Forbrig R; Ruf V; Wenter V; Kreth FW; Herms J; Bartenstein P; Tonn JC; Albert NL
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2581-2589. PubMed ID: 31410540
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic value of PET/CT with
Ogawa T; Kawai N; Miyake K; Shinomiya A; Yamamoto Y; Nishiyama Y; Tamiya T
EJNMMI Res; 2020 May; 10(1):44. PubMed ID: 32382870
[TBL] [Abstract][Full Text] [Related]
7. Re-evaluation of the diagnostic performance of
Kim D; Chun JH; Kim SH; Moon JH; Kang SG; Chang JH; Yun M
Eur J Nucl Med Mol Imaging; 2019 Jul; 46(8):1678-1684. PubMed ID: 31102001
[TBL] [Abstract][Full Text] [Related]
8. Sex-specific radiomic features of L-[S-methyl-
Papp L; Rasul S; Spielvogel CP; Krajnc D; Poetsch N; Woehrer A; Patronas EM; Ecsedi B; Furtner J; Mitterhauser M; Rausch I; Widhalm G; Beyer T; Hacker M; Traub-Weidinger T
Front Oncol; 2023; 13():986788. PubMed ID: 36816966
[TBL] [Abstract][Full Text] [Related]
9. Hybrid 11C-MET PET/MRI Combined With "Machine Learning" in Glioma Diagnosis According to the Revised Glioma WHO Classification 2016.
Kebir S; Weber M; Lazaridis L; Deuschl C; Schmidt T; Mönninghoff C; Keyvani K; Umutlu L; Pierscianek D; Forsting M; Sure U; Stuschke M; Kleinschnitz C; Scheffler B; Colletti PM; Rubello D; Rischpler C; Glas M
Clin Nucl Med; 2019 Mar; 44(3):214-220. PubMed ID: 30516675
[TBL] [Abstract][Full Text] [Related]
10. Individualized discrimination of tumor progression from treatment-related changes in different types of adult-type diffuse gliomas using [
Chen Q; Wang K; Ren X; Zhao X; Chen Q; Fan D; Zhang S; Li X; Ai L
J Neurooncol; 2023 Dec; 165(3):547-559. PubMed ID: 38095773
[TBL] [Abstract][Full Text] [Related]
11. Fractal analysis of
Maeda Y; Yamamoto Y; Norikane T; Mitamura K; Hatakeyama T; Miyake K; Nishiyama Y; Kudomi N
EJNMMI Phys; 2021 Nov; 8(1):76. PubMed ID: 34743250
[TBL] [Abstract][Full Text] [Related]
12. Conventional MR-based Preoperative Nomograms for Prediction of IDH/1p19q Subtype in Low-Grade Glioma.
Liu Z; Zhang T; Jiang H; Xu W; Zhang J
Acad Radiol; 2019 Aug; 26(8):1062-1070. PubMed ID: 30393056
[TBL] [Abstract][Full Text] [Related]
13. Radiological Prediction of Isocitrate Dehydrogenase (IDH) Mutational Status and Pathological Verification for Lower-Grade Astrocytomas.
Yano H; Ikegame Y; Miwa K; Nakayama N; Maruyama T; Ikuta S; Yokoyama K; Muragaki Y; Iwama T; Shinoda J
Cureus; 2022 Jul; 14(7):e27157. PubMed ID: 36017268
[TBL] [Abstract][Full Text] [Related]
14. Comparison of L-Methyl-11C-Methionine PET With Magnetic Resonance Spectroscopy in Detecting Newly Diagnosed Glioma.
Kebir S; Lazaridis L; Weber M; Deuschl C; Stoppek AK; Schmidt T; Mönninghoff C; Blau T; Keyvani K; Umutlu L; Pierscianek D; Forsting M; Stuschke M; Antoch G; Sure U; Kleinschnitz C; Scheffler B; Colletti PM; Rubello D; Herrmann K; Glas M
Clin Nucl Med; 2019 Jun; 44(6):e375-e381. PubMed ID: 30985412
[TBL] [Abstract][Full Text] [Related]
15. Whole-tumor histogram analysis of synthetic magnetic resonance imaging predicts isocitrate dehydrogenase mutation status in gliomas.
Ge X; Gan T; Yang Z; Liu G; Hu W; Ma W; Bai Y; Xiong Y; Li M; Zhao J; Zhou L; Li J; Li D; Wang X; Zhang J
Quant Imaging Med Surg; 2024 Mar; 14(3):2225-2239. PubMed ID: 38545061
[TBL] [Abstract][Full Text] [Related]
16.
Cicone F; Carideo L; Scaringi C; Arcella A; Giangaspero F; Scopinaro F; Minniti G
Ann Nucl Med; 2019 Apr; 33(4):295-302. PubMed ID: 30607877
[TBL] [Abstract][Full Text] [Related]
17.
Zhao X; Li D; Qiao Z; Wang K; Chen Q; Pan C; Wu Y; Xiao D; Xi T; Zhang L; Ai L
Eur J Nucl Med Mol Imaging; 2023 May; 50(6):1709-1719. PubMed ID: 36697961
[TBL] [Abstract][Full Text] [Related]
18. IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein-specific PET/CT.
Röhrich M; Loktev A; Wefers AK; Altmann A; Paech D; Adeberg S; Windisch P; Hielscher T; Flechsig P; Floca R; Leitz D; Schuster JP; Huber PE; Debus J; von Deimling A; Lindner T; Haberkorn U
Eur J Nucl Med Mol Imaging; 2019 Nov; 46(12):2569-2580. PubMed ID: 31388723
[TBL] [Abstract][Full Text] [Related]
19. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake.
Tanaka K; Yamamoto Y; Maeda Y; Yamamoto H; Kudomi N; Kawai N; Toyohara J; Nishiyama Y
Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019
[TBL] [Abstract][Full Text] [Related]
20. Predicting IDH mutation status in grade II gliomas using amide proton transfer-weighted (APTw) MRI.
Jiang S; Zou T; Eberhart CG; Villalobos MAV; Heo HY; Zhang Y; Wang Y; Wang X; Yu H; Du Y; van Zijl PCM; Wen Z; Zhou J
Magn Reson Med; 2017 Sep; 78(3):1100-1109. PubMed ID: 28714279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
